StockOtters
StockOttersSupply Chain Map
Teva Pharmaceutical Industries Limited logo

Teva Pharmaceutical Industries Limited

TEVA

Financial Statements

Income Statement (Annual)

Amounts in millions

2024

12/31/2024

Revenue
16,544
Cost of Revenue
8,481
Gross Profit
8,063
Gross Margin
48.7%
Operating Income
-303
Operating Margin
-1.8%
Net Income
-1,639
Net Margin
-9.9%
EPS (Basic)
$-1.45
EPS (Diluted)
$-1.45
EBITDA
4,431
EBITDA Margin
26.8%

2023

12/31/2023

Revenue
15,845
Cost of Revenue
8,200
Gross Profit
7,645
Gross Margin
48.2%
Operating Income
433
Operating Margin
2.7%
Net Income
-559
Net Margin
-3.5%
EPS (Basic)
$-0.50
EPS (Diluted)
$-0.50
EBITDA
1,558
EBITDA Margin
9.8%

2022

12/31/2022

Revenue
14,925
Cost of Revenue
7,952
Gross Profit
6,973
Gross Margin
46.7%
Operating Income
-2,197
Operating Margin
-14.7%
Net Income
-2,446
Net Margin
-16.4%
EPS (Basic)
$-2.20
EPS (Diluted)
$-2.20
EBITDA
-925
EBITDA Margin
-6.2%

2021

12/31/2021

Revenue
15,878
Cost of Revenue
8,284
Gross Profit
7,594
Gross Margin
47.8%
Operating Income
1,716
Operating Margin
10.8%
Net Income
417
Net Margin
2.6%
EPS (Basic)
$0.38
EPS (Diluted)
$0.38
EBITDA
4,409
EBITDA Margin
27.8%

2020

12/31/2020

Revenue
16,659
Cost of Revenue
8,933
Gross Profit
7,726
Gross Margin
46.4%
Operating Income
-3,572
Operating Margin
-21.4%
Net Income
-3,990
Net Margin
-24.0%
EPS (Basic)
$-3.64
EPS (Diluted)
$-3.64
EBITDA
4,612
EBITDA Margin
27.7%